CUMBERLAND PHARMACEUTICALS (CPIX)
US2307701092 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.33M | -5.65M | -3.60M | -3.42M | -3.55M | |||
| Depreciation Amortization | 4.94M | 5.33M | 4.61M | 4.75M | 4.40M | |||
| Income Taxes - Deferred | N/A | 0.00 | 0.00 | 20.00K | 70.00K | |||
| Change In Working Capital | 4.63M | 10.44M | 8.18M | 3.53M | 1.43M | |||
| Interest Paid | 647.14K | 523.16K | 63.98K | 220.00K | 200.00K | |||
| Taxes Paid | 108.82K | 3.30K | -330.00 | -90.00K | 20.00K | |||
| Other non cash items | 2.85M | -1.67M | -2.84M | 530.00K | 700.00K | |||
| OPERATING CASH FLOW | 6.09M | 8.45M | 6.34M | 5.42M | 3.06M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -453.05K | -2.07M | -354.46K | -2.11M | -1.02M | |||
| Other Investing Activity | 347.36K | -11.60M | -147.43K | 360.00K | 3.32M | |||
| INVESTING CASH FLOW | -105.70K | -13.67M | -501.89K | -1.76M | 2.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.42M | 1.20M | 0.00 | -3.50M | -1.50M | |||
| Stock Issued/Repurchased | -740.53K | -1.05M | -1.39M | -1.85M | -3.49M | |||
| Other Financing Activity | -3.27M | -2.21M | -2.17M | -1.76M | -90.00K | |||
| FINANCING CASH FLOW | -7.42M | -2.06M | -3.55M | -7.12M | -5.08M | |||
| CHANGE IN CASH | -1.44M | -7.28M | 2.29M | -3.46M | 280.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 6.09M | 8.45M | 6.34M | 5.42M | 3.06M | |||
| Capital Expenditure | -453.05K | -2.07M | -354.46K | -2.11M | -1.02M | |||
| FREE CASH FLOW | 5.64M | 6.38M | 5.99M | 3.31M | 2.04M | |||
All data in USD